The associations between CXCL13 serum and saliva levels and various histologic, clinical and laboratory parameters (summarized in Table 2) that have been associated with severe, systemic disease and/or NHL development have been examined. The gene discussed is CXCL13; the disease is non-Hodgkin lymphoma.